Geneoscopy is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designated from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Preliminary trials suggest that the diagnostic can detect these lesions at a higher rate than all existing noninvasive screening tests.
Geneoscopy Address
2220 Welsch Industrial Ct St. Louis, MO United States
Geneoscopy Email
Past Companies
GeneoscopyVice President, Market Access and Revenue Cycle Management
Strata OncologyVice President, Market Access
Interpace BiosciencesVice President, Managed Care & Payer Relations